The application council of the US Center for Disease Control and Prevention (CDC) scientists recommended that Pfizer-BionNTech or Moderna vaccines be made instead of the Johnson & Johnson vaccine against COVID-19.
At the science application council meeting held within the CDC, it was stated that it would be more appropriate to administer Pfizer-BionNTech or Moderna vaccines instead of the Johnson & Johnson vaccine, which can cause blood clots, albeit rarely.
CDC consultants mentioned that the coagulation problem of Johnson & Johnson vaccines caused the death of 9 people in the country, and noted that the other two vaccines did not carry such a risk and seemed more effective.
CDC’s Dr. Isaac See, in his previous statement, informed that 54 blood clotting incidents were seen in men and women who had the Johnson & Johnson vaccine, 9 people, two of whom were men, died because of this, and the other two deaths were suspected to be due to the exact cause.
CDC’s director, Rochelle Walensky, must decide whether to implement the recommendation, which has been described as an “unusual move”.
More than 200 million Americans are considered fully vaccinated, including the nearly 16 million people who have received the Johnson & Johnson vaccine since the vaccine was introduced a year ago.